8.5 USD
+0.24 (+2.91%)
We assign a fundamental rating of 2 out of 10 to EKSO. EKSO was compared to 184 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of EKSO have multiple concerns. While showing a medium growth rate, EKSO is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
- EKSO had negative earnings in the past year.
- In the past year EKSO has reported a negative cash flow from operations.
- EKSO had negative earnings in each of the past 5 years.
- EKSO had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- EKSO's Return On Assets of -49.21% is on the low side compared to the rest of the industry. EKSO is outperformed by 66.30% of its industry peers.
- With a Return On Equity value of -110.14%, EKSO is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -49.21% | ||
| ROE | -110.14% | ||
| ROIC | N/A |
ROA(3y)-43.98%
ROA(5y)-46.15%
ROE(3y)-89.67%
ROE(5y)-131.07%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- EKSO has a Gross Margin (53.48%) which is in line with its industry peers.
- EKSO's Gross Margin has improved in the last couple of years.
- The Profit Margin and Operating Margin are not available for EKSO so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 53.48% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.01%
GM growth 5Y1.79%
2. Health
2.1 Basic Checks
- EKSO does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for EKSO has been increased compared to 1 year ago.
- The number of shares outstanding for EKSO has been increased compared to 5 years ago.
- EKSO has a better debt/assets ratio than last year.
2.2 Solvency
- EKSO has an Altman-Z score of -15.91. This is a bad value and indicates that EKSO is not financially healthy and even has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of -15.91, EKSO is doing worse than 84.78% of the companies in the same industry.
- EKSO has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
- EKSO's Debt to Equity ratio of 0.31 is in line compared to the rest of the industry. EKSO outperforms 50.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -15.91 |
ROIC/WACCN/A
WACC9.57%
2.3 Liquidity
- A Current Ratio of 1.66 indicates that EKSO should not have too much problems paying its short term obligations.
- EKSO's Current ratio of 1.66 is on the low side compared to the rest of the industry. EKSO is outperformed by 70.11% of its industry peers.
- EKSO has a Quick Ratio of 1.09. This is a normal value and indicates that EKSO is financially healthy and should not expect problems in meeting its short term obligations.
- EKSO has a worse Quick ratio (1.09) than 72.83% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.66 | ||
| Quick Ratio | 1.09 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 41.74% over the past year.
- Looking at the last year, EKSO shows a very negative growth in Revenue. The Revenue has decreased by -16.59% in the last year.
- Measured over the past years, EKSO shows a small growth in Revenue. The Revenue has been growing by 5.19% on average per year.
EPS 1Y (TTM)41.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64%
Revenue 1Y (TTM)-16.59%
Revenue growth 3Y16.8%
Revenue growth 5Y5.19%
Sales Q2Q%2.37%
3.2 Future
- Based on estimates for the next years, EKSO will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.47% on average per year.
- EKSO is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.94% yearly.
EPS Next Y74.41%
EPS Next 2Y39.68%
EPS Next 3Y25.84%
EPS Next 5Y16.47%
Revenue Next Year-17.71%
Revenue Next 2Y12.81%
Revenue Next 3Y10.94%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- EKSO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EKSO. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- EKSO's earnings are expected to grow with 25.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.68%
EPS Next 3Y25.84%
5. Dividend
5.1 Amount
- EKSO does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
EKSO BIONICS HOLDINGS INC / EKSO FAQ
Can you provide the ChartMill fundamental rating for EKSO BIONICS HOLDINGS INC?
ChartMill assigns a fundamental rating of 2 / 10 to EKSO.
What is the valuation status for EKSO stock?
ChartMill assigns a valuation rating of 1 / 10 to EKSO BIONICS HOLDINGS INC (EKSO). This can be considered as Overvalued.
What is the profitability of EKSO stock?
EKSO BIONICS HOLDINGS INC (EKSO) has a profitability rating of 1 / 10.
Can you provide the financial health for EKSO stock?
The financial health rating of EKSO BIONICS HOLDINGS INC (EKSO) is 2 / 10.
Can you provide the expected EPS growth for EKSO stock?
The Earnings per Share (EPS) of EKSO BIONICS HOLDINGS INC (EKSO) is expected to grow by 74.41% in the next year.